methamphetamine and Acquired Metabolic Diseases, Brain

methamphetamine has been researched along with Acquired Metabolic Diseases, Brain in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Harano, M; Hori, T; Inada, T; Iwata, N; Iyo, M; Komiyama, T; Kotaka, T; Kuroda, S; Okahisa, Y; Otani, K; Ozaki, N; Sakai, A; Sekine, Y; Sora, I; Ujike, H; Yamada, M	1

Other Studies

1 other study(ies) available for methamphetamine and Acquired Metabolic Diseases, Brain

Article	Year
Reduced CYP2D6 activity is a negative risk factor for methamphetamine dependence. Neuroscience letters, 2008, Mar-21, Volume: 434, Issue:1 Topics: Adult; Amphetamine-Related Disorders; Brain; Brain Diseases, Metabolic; Case-Control Studies; Central Nervous System Stimulants; Cytochrome P-450 CYP2D6; DNA Mutational Analysis; Down-Regulation; Female; Gene Expression Regulation, Enzymologic; Gene Frequency; Genetic Predisposition to Disease; Genetic Testing; Genotype; Humans; Inactivation, Metabolic; Japan; Male; Methamphetamine; Middle Aged; Risk Factors	2008

Article

Year

Reduced CYP2D6 activity is a negative risk factor for methamphetamine dependence.

Neuroscience letters, 2008, Mar-21, Volume: 434, Issue:1

Topics: Adult; Amphetamine-Related Disorders; Brain; Brain Diseases, Metabolic; Case-Control Studies; Central Nervous System Stimulants; Cytochrome P-450 CYP2D6; DNA Mutational Analysis; Down-Regulation; Female; Gene Expression Regulation, Enzymologic; Gene Frequency; Genetic Predisposition to Disease; Genetic Testing; Genotype; Humans; Inactivation, Metabolic; Japan; Male; Methamphetamine; Middle Aged; Risk Factors

2008